cAMP-mediated inhibition of DNA replication and S phase rogression: Involvement of Rb, p21Cip1, and PCNA

Molecular Biology of the Cell

Volumn 16, Issue 3, 2005, Pages 1527-1542

  Naderi, Soheil ^a   Wang, Jean Y J ^b   Chen, Tung Ti ^c   Gutzkow, Kristine B ^a   Blomhoff, Heidi K ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AmProx Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; CHOLERA TOXIN; CYCLIC AMP; CYCLINE; DNA; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; PROTEIN P21; RETINOBLASTOMA PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL PROTECTION; CELL TYPE; CHROMATIN STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DNA REPLICATION; DNA SYNTHESIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYMPHOCYTE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN; CLONING, MOLECULAR; CYCLIC AMP; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FORSKOLIN; G1 PHASE; HUMANS; IMMUNOBLOTTING; LYMPHOCYTES; MICE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NIH 3T3 CELLS; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; RETINOBLASTOMA PROTEIN; S PHASE; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TIME FACTORS;

EID: 14844302793     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-06-0501     Document Type: Article

References (95)

1. Alleva, D. G., Burger, C. J., and Elgert, K. D. (1993). Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2, changes in macrophage suppressor activity. J. Leukoc. Biol. 53, 550-558.
2. Angus, S. P., Mayhew, C. N., Solomon, D. A., Braden, W. A., Markey, M. P., Okuno, Y., Cardoso, M. C., Gilbert, D. M., and Knudsen, E. S. (2004). RB reversibly inhibits DNA replication via two temporally distinct mechanisms. Mol. Cell Biol. 24, 5404-5420.
3. Avni, D., Yang, H., Martelli, F., Hofmann, F., ElShamy, W. M., Ganesan, S., Scully, R., and Livingston, D. M. (2003). Active localization of the retinoblastoma protein in chromarin and its response to S phase DNA damage. Mol. Cell 12, 735-746.
4. Beavo, J. A., and Reifsnyder, D. H. (1990). Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11, 150-155.
5. Beavo, J. A., Rogers, N. L., Crofford, O. B., Hardman, J. G., Sutherland, E. W., and Newman, E. V. (1970). Effects of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity. Mol. Pharmacol. 6, 597-603.
6. Blomhoff, H. K., Blomhoff, R., Stokke, T., deLange, D. C., Brevik, K., Smeland, E. B., Funderud, S., and Godal, T. (1988). cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1. J. Cell Physiol. 137, 583-587.
7. Blomhoff, H. K., Smeland, E. B., Beiske, K., Blomhoff, R., Ruud, E., Bjoro, T., Pfeifer-Ohlsson, S., Watt, R., Funderud, S., and Godal, T. (1987). Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J. Cell Physiol. 131, 426-433.
8. Bosco, G., Du, W., and Orr-Weaver, T. L. (2001). DNA replication control through interaction of E2F-RB and the origin recognition complex. Nat. Cell Biol. 3, 289-295.
9. Brum-Fernandes, A. J., Morisset, S., Bkaily, G., and Parry, C. (1996). Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture. Br. J. Pharmacol. 118, 1597-1604.
10. Cazzalini, O., Perucca, P., Riva, F., Stivala, L. A., Blanchi, L., Vannini, V., Ducommun, B., and Prosperi, E. (2003). p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition. Cell Cycle 2, 596-603.
11. Chau, B. N., Borges, H. L., Chen, T. T., Masselli, A., Hunton, I. C., and Wang, J. Y. (2002). Signal-dependent protection from apoptosis in mice expressing caspase- resistant Rb. Nat. Cell Biol. 4, 757-765.
12. Chen, T. T., and Wang, J. Y. (2000). Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol. Cell Biol. 20, 5571-5580.
13. Chew, Y. P., Ellis, M., Wilkie, S., and Mittnacht, S. (1998). pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F. Oncogene 17, 2177-2186.
14. Christoffersen, J., Smeland, E. B., Stokke, T., Tasken, K., Andersson, K. B., and Blomhoff, H. K. (1994). Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells. Cancer Res. 54, 2245-2250.
15. Coleman, R. A., Smith, W. L., and Narumiya, S. (1994). International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46, 205-229.
16. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Traganos, F. (1992). Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808.
17. Darzynkiewicz, Z., Li, X., and Gong, J. (1994). Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol. 41, 15-38.
18. Diffley, J. F. (1996). Once and only once upon a time: specifying and regulating origins of DNA replication in eukaryotic cells. Genes Dev. 10, 2819-2830.
19. Dimitrova, D. S., and Berezney, R. (2002). The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells. J. Cell Sci. 115, 4037-4051.
20. Dimitrova, D. S., and Gilbert, D. M. (2000). Temporally coordinated assembly and disassembly of replication factories in the absence of DNA synthesis. Nat. Cell Biol. 2, 686-694.
21. Dimitrova, D. S., Todorov, I. T., Melendy, T., and Gilbert, D. M. (1999). Mcm2, but not RPA, is a component of the mammalian early G1-phase prereplication complex. J. Cell Biol. 146, 709-722.
22. Dugan, L. L., Kim, J. S., Zhang, Y., Bart, R. D., Sun, Y., Holtzman, D. M., and Gutmann, D. H. (1999). Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J. Biol. Chem. 274, 25842-25848.
23. Dumont, J. E., Jauniaux, J. C., and Roger, P. P. (1989). The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14, 67-71.
24. Dutta, A., and Bell, S. P. (1997). Initiation of DNA replication in eukaryotic cells. Annu. Rev. Cell Dev. Biol. 33, 293-332.
25. el Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
26. Elgert, K. D., Alleva, D. G., and Mullins, D. W. (1998). Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol. 64, 275-290.
27. Ferlini, C., Di Cesare, S., Rainaldi, G., Malorni, W., Samoggia, P., Biselli, R., and Fattorossi, A. (1996). Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 24, 106-115.
28. Fickenscher, H., Stamminger, T., Ruger, R., and Fleckenstein, B. (1989). The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate early enhancer. J. Gen. Virol. 70(Pt 1), 107-123.
29. Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O'Donnell, M., and Hurwitz, J. (1994). Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc. Natl. Acad. Sci. USA 91, 8655-8659.
30. Furstenthal, L., Kaiser, B. K., Swanson, C., and Jackson, P. K. (2001). Cyclin E uses Cdc6 as a chromatin-associated receptor required for DNA replication. J. Cell Biol. 152, 1267-1278.
31. Gray, N., Detivaud, L., Doerig, C., and Meijer, L. (1999). ATP-site directed inhibitors of cyclin-dependent kinases. Curr. Med. Chem. 6, 859-875.
32. Gutzkow, K. B., Naderi, S., and Blomhoff, H. K. (2002). Forskolin-mediated G1 arrest in acute lymphoblastic leukaemia cells: phosphorylated pRB sequesters E2Fs. J. Cell Sci. 335, 1073-1082.
33. Hannon, G. J., and Beach, D. (1994). p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371, 257-261.
34. Harbour, J. W., and Dean, D. C. (2000). The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409.
35. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
36. Helin, K. (1998). Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8, 28-35.
37. Hirai, H., Roussel, M. F., Kato, J. Y., Ashmun, R. A., and Sherr, C. J. (1995). Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15, 2672-2681.
38. Hoshi, T., Garber, S. S., and Aldrich, R. W. (1988). Effect of forskolin on voltage-gated K+ channels is independent of adenylate cyclase activation. Science 240, 1652-1655.
39. Jiang, W., Wells, N. J., and Hunter, T. (1999). Multistep regulation of DNA replication by Cdk phosphorylation of HsCdc6. Proc. Natl. Acad. Sci. USA 96, 6193-6198.
40. Joost, H. G., and Steinfelder, H. J. (1987). Forskolin inhibits insulin-stimulated glucose transport in rat adipose cells by a direct interaction with the glucose transporter. Mol. Pharmacol. 31, 279-283.
41. Jordan, A., Hadfield, J. A., Lawrence, N. J., and McGown, A. T. (1998). Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med. Res. Rev. 18, 259-296.
42. Jordan, M. A. (2002). Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr. Med. Chem. Anti.-Canc. Agents 2, 1-17.
43. Kaelin, W. G., Jr. (1999). Functions of the retinoblastoma protein. Bioessays 23, 950-958.
44. Kelly, T. J., and Brown, G. W. (2000). Regulation of chromosome replication. Annu. Rev. Biochem. 69, 829-880.
45. Kelman, Z. (1997). PCNA: structure, functions and interactions. Oncogene 34, 629-640.
46. Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., and Narumiya, S. (1997). Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 122, 217-224.
47. Knudsen, E. S., Buckmaster, C., Chen, T. T., Feramisco, J. R., and Wang, J. Y. (1998). Inhibition of DNA synthesis by RB: effects on G1/S transition and S phase progression. Genes Dev. 12, 2278-2292.
48. Knudsen, K. E., Booth, D., Naderi, S., Sever-Chroneos, Z., Fribourg, A. F., Hunton, I. C., Feramisco, J. R., Wang, J. Y., and Knudsen, E. S. (2000). RB-dependent S phase response to DNA damage. Mol. Cell Biol. 20, 7751-7763.
49. Laurenza, A., Sutkowski, E. M., and Seamon, K. B. (1989). Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol. Sci. 10, 442-447.
50. Leone, G., DeGregori, J., Van, Z., Jakoi, L., Ishida, S., Williams, R. S., and Nevins, J. R. (1998). E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12, 2120-2130.
51. Liu, L. F., Desai, S. D., Li, T. K., Mao, Y., Sun, M., and Sim, S. P. (2000). Mechanism of action of camptothecin. Ann. NY Acad. Sci. 922, 1-10.
52. Lundberg, A. S., and Weinberg, R. A. (1998). Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell Biol. 18, 753-761.
53. Luo, Y., Hurwitz, J., and Massague, J. (1995). Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375, 159-161.
54. Mimura, S., and Takisawa, H. (1998). Xenopus Cdc45-dependent loading of DNA polymerase alpha onto chromatin under the control of S phase Cdk. EMBO J. 17, 5699-5707.
55. Mittnacht, S. (1998). Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8, 21-27.
56. Morgan, D. O. (1995). Principles of CDK regulation. Nature 374, 131-134.
57. Morgenstern, J. P., and Land, H. (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
58. Naderi, S., and Blomhoff, H. K. (1999). Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh. J. Cell Physiol. 178, 76-84.
59. Nakanishi, M., Robetorye, R. S., Adami, G. R., Pereira-Smith, O. M., and Smith, J. R. (1995a). Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J. 14, 555-563.
60. Nakanishi, M., Robetorye, R. S., Pereira-Smith, O. M., and Smith, J. R. (1995b). The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J. Biol. Chem. 270, 17060-17063.
61. Negishi, M., Sugimoto, Y., and Ichikawa, A. (1993). Prostanoid receptors and their biological actions. Prog. Lipid Res. 32, 417-434.
62. Niculescu, A. B., III, Chen, X., Smeets, M., Hengst, L., Prives, C., and Reed, S. I. (1998). Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629-643.
63. Ogryzko, V. V., Wong, P., and Howard, B. H. (1997). WAF1 retards S phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell Biol. 27, 4877-4882.
64. Ormerod, M. G., Collins, M. K., Rodriguez-Tarduchy, G., and Robertson, D. (1992). Apoptosis in interleukin-3-dependent haemopoietic cells. Quantification by two flow cytometric methods. J. Immunol. Methods 153, 57-65.
65. Pastan, I. H., Johnson, G. S., and Anderson, W. B. (1975). Role of cyclic nucleotides in growth control. Annu. Rev. Biochem. 44, 491-522.
66. Pennaneach, V. et al. (2001). The large subunit of replication factor C promotes cell survival after DNA damage in an LxCxE motif- and Rb-dependent manner. Mol. Cell 7, 715-727.
67. Petersen, B. O., Lukas, J., Sorensen, C. S., Bartek, J., and Helin, K. (1999). Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J. 18, 396-410.
68. Podust, V. N., Podust, L. M., Goubin, F., Ducommun, B., and Hubscher, U. (1995). Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry 34, 8869-8875.
69. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
70. Regan, J. W. (2003). EP2 and EP4 prostanoid receptor signaling. Life Sci. 74, 143-153.
71. Resnitzky, D., Hengst, L., and Reed, S. I. (1995). Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol. Cell Biol. 35, 4347-4352.
72. Rosenfeld, C., Goutner, A., Choquet, C., Venuat, A. M., Kayibanda, B., Pico, J. L., and Greaves, M. F. (1977). Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature 267, 841-843.
73. Sampath, D., Rao, V. A., and Plunkett, W. (2003). Mechanisms of apoptosis induction by nucleoside analogs. Oncogene 22, 9063-9074.
74. Saudan, P., Vlach, J., and Beard, P. (2000). Inhibition of S phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J. 19, 4351-4361.
75. Scott, J. D. (1991). Cyclic nucleotide-dependent protein kinases. Pharmacol. Ther. 50, 123-145.
76. 3H]forskolin to rat brain membranes. Proc. Natl. Acad. Sci. USA 81, 5081-5085.
77. Serrano, M., Hannon, G. J., and Beach, D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
78. Sever-Chroneos, Z., Angus, S. P., Fribourg, A. F., Wan, H., Todorov, I., Knudsen, K.E., and Knudsen, E. S. (2001). Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase. Mol. Cell Biol. 23, 4032-4045.
79. Sherr, C. J., and Roberts, J. M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9, 1149-1163.
80. Skalhegg, B. S., Landmark, B. F., Doskeland, S. O., Hansson, V., Lea, T., and Jahnsen, T. (1992). Cyclic AMP-dependent protein kinase type I mediates the inhibitory effects of 3′,5′-cyclic adenosine monophosphate on cell replication in human T lymphocytes. J. Biol. Chem. 267, 15707-15714.
81. Spangler, B. D. (1992). Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56, 622-647.
82. Sterner, J. M., Dew-Knight, S., Musahl, C., Kornbluth, S., and Horowitz, J. M. (1998). Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol. Cell Biol. 18, 2748-2757.
83. Tasken, K., Andersson, K. B., Erikstein, B. K., Hansson, V., Jahnsen, T., and Blomhoff, H. K. (1994). Regulation of growth in a neoplastic B cell line by transfected subunits of 3′,5′-cyclic adenosine monophosphate- dependent protein kinase. Endocrinology 335, 2109-2119.
84. Todorov, I. T., Attaran, A., and Kearsey, S. E. (1995). BM28, a human member of the MCM2-3-5 family, is displaced from chromatin during DNA replication. J. Cell Biol. 329, 1433-1445.
85. Toyoshima, H., and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
86. Waga, S., Hannon, G. J., Beach, D., and Stillman, B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578.
87. Waga, S., and Stillman, B. (1998). The DNA replication fork in eukaryotic cells. Annu. Rev. Biochem. 67, 721-751.
88. Wang, J. Y., Knudsen, E. S., and Welch, P. J. (1994). The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64, 25-85.
89. Wang, X., Guan, J., Hu, B., Weiss, R. S., Iliakis, G., and Wang, Y. (2004). Involvement of Hus1 in the chain elongation step of DNA replication after exposure to camptothecin or ionizing radiation. Nucleic Acids Res. 32, 767-775.
90. Watanabe, I. (1974). Radiation effects on DNA chain growth in mammalian cells. Radiat. Res. 58, 541-556.
91. Witz, I. P. (2001). Presence and functions of immune components in the tumor microenvironment. Adv. Exp. Med. Biol. 495, 317-324.
92. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
93. Yarbro, J. W. (1992). Mechanism of action of hydroxyurea. Semin. Oncol. 19, 1-10.
94. Zarkowska, T., and Mittnacht, S. (1997). Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272, 12738-12746.
95. Zou, L., and Stillman, B. (1998). Formation of a preinitiation complex by S phase cyclin CDK-dependent loading of Cdc45p onto chromatin. Science 280, 593-596.